The new understanding of molecular events that drive the various forms of amyloidosis has generated treatment strategies that ...

Amyloidosis treatments can vary widely, depending on the patient and the affected organs and tissues. Likewise, treatment duration and possible number of hospital stays can vary considerably.

Amyloidosis is a rare condition defined by the abnormal production of proteins that bind together to form amyloid proteins.

Company management will provide an update on positive new developments regarding CAR-T NXC-201 in relapsed/refractory AL Amyloidosis. Following management’s formal remarks, there will be a ...

BNP Paribas Financial Markets grew its position in Prothena Co. plc (NASDAQ:PRTA – Free Report) by 44.6% during the third ...

The approval was lauded by the Amyloidosis Research Consortium, whose chief executive Isabelle Lousada said: "With this approval, Alnylam has expanded treatment options that may support ...

Janssen-Cilag International NV, a Johnson & Johnson company, announced data highlighting that DARZALEX® (daratumumab) subcutaneous (SC)-based regimens improve overall and sustained minimal residual ...

ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patientsNew analysis from the IMROZ phase 3 ...

New data from three oral presentations, which demonstrated significant clinical benefit with Sarclisa-based quadruplets in newly diagnosed multiple myeloma (NDMM) patients were featured at the 66th ...

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.

After hours: December 9 at 5:40:49 PM EST Loading Chart for ALNY ...